Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

tRNA Activation02:26

tRNA Activation

6.8K
6.8K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

7.3K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.3K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K
Activation Energy01:26

Activation Energy

79.9K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
79.9K
Spare Receptors01:30

Spare Receptors

3.6K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.6K
Sympathetic Activation01:17

Sympathetic Activation

5.4K
The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allosteric Induction of Estrogen Receptor Ligand Binding Domain Tetramerization by a Distinct Complete Estrogen Receptor Antagonist.

ACS medicinal chemistry letters·2026
Same author

Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α.

ACS pharmacology & translational science·2025
Same author

SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

bioRxiv : the preprint server for biology·2025
Same author

Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).

ACS omega·2025
Same author

Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

Science translational medicine·2025
Same author

Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC).

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jul 26, 2025

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
09:22

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters

Published on: November 26, 2013

14.6K

Alternative activation.

Kristen Young1, Sean Fanning1

  • 1Stritch School of Medicine, Loyola University Chicago, Maywood, United States.

Elife
|June 12, 2023
PubMed
Summary

Researchers discovered a novel mechanism by which ligands regulate the transcriptional activity of the orphan receptor Nurr1, a key player in neurodegenerative diseases.

Keywords:
NMR spectroscopybiochemistrybiophysicschemical biologyligand bindingmolecular biophysicsnonenuclear receptorsprotein-protein interactionstructural biologytranscription factors

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K
A Rapid In Vivo Bioassay for Developmentally Active Enhancers
00:08

A Rapid In Vivo Bioassay for Developmentally Active Enhancers

1.3K

Related Experiment Videos

Last Updated: Jul 26, 2025

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
09:22

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters

Published on: November 26, 2013

14.6K
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K
A Rapid In Vivo Bioassay for Developmentally Active Enhancers
00:08

A Rapid In Vivo Bioassay for Developmentally Active Enhancers

1.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Receptor Biology

Background:

  • The orphan receptor Nurr1 is a critical regulator in neuronal development and function.
  • Dysregulation of Nurr1 is implicated in various neurodegenerative diseases, including Parkinson's disease.
  • Understanding Nurr1's regulatory mechanisms is crucial for developing therapeutic strategies.

Discussion:

  • This study elucidates a previously unknown mode of ligand-mediated control over Nurr1's transcriptional activity.
  • The findings shed light on how small molecules can modulate Nurr1 function.
  • This research provides a new perspective on the allosteric regulation of nuclear receptors.

Key Insights:

  • A novel allosteric binding site for ligands on Nurr1 has been identified.
  • Ligand binding induces conformational changes that alter Nurr1's interaction with co-regulators.
  • This mechanism provides a new avenue for fine-tuning Nurr1's gene expression output.

Outlook:

  • The identified mechanism offers potential for developing targeted therapeutics for neurodegenerative disorders.
  • Further research could explore the therapeutic potential of modulating Nurr1 activity through this novel pathway.
  • This discovery may pave the way for new drug discovery efforts targeting Nurr1.